Valuation: ChemoMetec A/S

Capitalization 12.39B 1.92B 1.66B 1.54B 1.44B 2.68B 175B 2.88B 17.75B 7B 83.24B 7.21B 7.06B 304B P/E ratio 2026 *
51.6x
P/E ratio 2027 * 41.6x
Enterprise value 12B 1.86B 1.61B 1.49B 1.39B 2.59B 169B 2.79B 17.19B 6.78B 80.59B 6.98B 6.84B 294B EV / Sales 2026 *
20.7x
EV / Sales 2027 * 17.1x
Free-Float
96.32%
Yield 2026 *
0.97%
Yield 2027 * 1.04%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.71%
1 week+0.07%
Current month+3.56%
1 month+9.45%
3 months+6.27%
6 months+35.49%
Current year+3.56%
More quotes
1 week 691
Extreme 691
732.5
1 month 664
Extreme 664
732.5
Current year 672.5
Extreme 672.5
732.5
1 year 367
Extreme 367
804
3 years 255
Extreme 255
804
5 years 255
Extreme 255
1,149
10 years 25.4
Extreme 25.4
1,149
More quotes
Manager TitleAgeSince
Chief Executive Officer 33 12/03/2024
Chief Tech/Sci/R&D Officer - 19/12/2023
Chief Tech/Sci/R&D Officer - 30/11/2010
Director TitleAgeSince
Director/Board Member 67 30/09/2013
Director/Board Member 64 30/09/2014
Director/Board Member 50 -
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.71%+0.07%+36.40%+7.96% 1.92B
+0.08%+8.79%+33.03%+50.47% 13.74B
-0.02%-.--%-.--%+73.90% 12.57B
+1.56%+2.25%-17.55%-12.31% 7.63B
-0.27%-0.89%+15.41%-3.30% 6.56B
-5.11%+0.35%+14.08%+30.02% 5.8B
-1.61%-5.22%+1.41%+66.74% 5.1B
-1.56%-0.71%+18.04%+35.99% 4.92B
+0.05%-.--%+0.53%+17.40% 4.7B
-1.21%+0.07%+23.16%-52.15% 1.72B
Average -0.64%-0.30%+12.45%+21.47% 6.47B
Weighted average by Cap. -0.51%+1.05%+10.99%+34.10%
See all sector performances

Financials

2026 *2027 *
Net sales 579M 89.91M 77.51M 72.16M 67.18M 125M 8.16B 135M 830M 327M 3.89B 337M 330M 14.21B 694M 108M 92.87M 86.45M 80.48M 150M 9.77B 161M 994M 392M 4.66B 404M 396M 17.02B
Net income 242M 37.64M 32.45M 30.21M 28.12M 52.36M 3.42B 56.34M 347M 137M 1.63B 141M 138M 5.95B 306M 47.42M 40.88M 38.06M 35.43M 65.97M 4.3B 70.97M 438M 173M 2.05B 178M 174M 7.49B
Net Debt -394M -61.16M -52.72M -49.08M -45.69M -85.08M -5.55B -91.53M -565M -223M -2.65B -229M -225M -9.66B -506M -78.5M -67.68M -63M -58.65M -109M -7.12B -117M -725M -286M -3.4B -294M -288M -12.41B
More financial data * Estimated data
Logo ChemoMetec A/S
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Employees
170
More about the company
Date Price Change Volume
16/01/26 712.00 kr +1.71% 20,061
15/01/26 700.00 kr -1.27% 25,740
14/01/26 709.00 kr -1.94% 18,895
13/01/26 723.00 kr +0.49% 22,489
12/01/26 719.50 kr +1.12% 14,997

Delayed Quote Nasdaq Copenhagen, January 16, 2026 at 04:20 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
712.00DKK
Average target price
870.00DKK
Spread / Average Target
+22.19%
Consensus

Quarterly revenue - Rate of surprise